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ABSTRACT 
Bodies in Pain: An Examination of Complex Regional Pain Syndrome 
Sonia C. Williams 
Lloyd Ackert Supervisor, Ph.D. 
 
The system of patient health includes all individuals and groups who influence 
treatment for patients.   This system includes scientists and researchers, government 
institutions, medical professionals, pharmaceutical companies, insurance companies, 
and patients who together establish a knowledge base and belief system about 
treatment, pain, diagnosis, and disease; and define ways in which diseases are 
categorized, experienced, interpreted, and managed.  Thus, diseases are embedded in 
social contexts, in which patients play a role in determining their own health and care.  
The neurological disease, Complex Regional Pain Syndrome (CRPS) offers a 
contemporary case study based on historical ideas of how neurologists have studied 
and treated pain.  Notably, the diverging fields of neurology and psychiatry 
throughout the 20th century left experts on both sides vying for authoritative claim 
over certain diseases, while disciplinary lines once again became blurred over other 
“fringe” diseases.  Moreover, issues of blame, responsibility, knowledge and 
authority are assigned to different groups, where society and history each play a part.   
Pain is a complex mechanism which doctors and historians have struggled to 
understand for centuries.  Understanding pain is thus an important part of the history 
of medicine.  It is a global problem, perhaps the most daunting problem with which 
contemporary researchers struggle.  It is no wonder that doctors who research pain are 
drawn to CRPS, the most painful of all painful diseases.  CRPS fits into a long history 
of how doctors and historians have studied pain and disease.  The history of 
 vi
neurology informs us of how CRPS is studied today, where doctors like Schwartzman 
are an example of how and why people are finding new techniques to alleviate pain 
within a contemporary model of chronic pain management and against the backdrop 
of the universal human experience. 
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CHAPTER I: INTRODUCTION TO COMPLEX REGIONAL PAIN 
SYNDROME (CRPS) 
 
Imagine if your pain never subsided? If a simple twist of the ankle or bump of 
the knee left you in such excruciating pain that you could not bear even the sensation 
of a warm breeze on a summer night. As difficult as this may be to imagine, more 
than five million Americans suffer from this kind of debilitating pain disease every 
minute of every day.  This disorder called Complex Regional Pain Syndrome (CRPS) 
is a chronic pain condition that some neurologists believe results from a dysfunction 
in the central or peripheral nervous systems.  For many patients including the two 
discussed below finding a doctor who is able to identify the disorder and relate some 
form of treatment is as agonizing as the pain itself.  
Barbara, a healthy, active woman in her early sixties was taking a walk in the 
park in New York City when she tripped and banged her knee. After a few days, the 
bruise did not heal but instead felt as though a violent toothache had attacked the area, 
while something as simple as the breeze from the air-conditioner hitting her skin was 
too much to bear. After two weeks, she could no longer bend or fully straighten her 
leg, and the piercing spasms left her unable to sleep. Barbara saw four orthopedic 
specialists and a neurologist, each of which offered a different painkiller, but no real 
explanation as to why she could no longer walk normally or even take a trip to the 
movie theatre for fear her leg would brush up against the seat in front of her. Finally, 
after consulting a physical therapist she had seen for a different injury in the past, 
Barbara learned that she may be suffering from CRPS, and began her study to learn 
more about the disorder that had send her spiraling into depression. 
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Unfortunately, even after Barbara had discovered that this may be exactly 
what she was suffering from, she was still met with resistance from doctors insisting 
that CRPS was not the case after initial treatments of injections referred to as nerve 
blocks from a pain specialist did not cure the debilitation. After more misdiagnoses of 
cancer and Lyme disease, Barbara returned to the pain specialist and resumed 
treatments that offered temporary relief, with hopes that the mysterious pain that 
resulted from such a small injury will one day be cured.1  
Not all cases are so fraught with anguish.  Proper diagnosis can be made and a 
treatment plan can be implemented to help the patient.  Research physicians like 
Robert Schwartzman, M.D., Chairman of Neurology at Drexel University College of 
Medicine, are exploring treatments which are giving patients new options and hope. 
For 14 year-old Lindsay Wurtenburg, it began as a mysterious pain from a 
spider bite.  A few months after the bite the energetic, dancer teenager was in a 
wheelchair and out of school, debilitated by an excruciating ache that began in one 
leg and soon spread throughout her body.  The pain was so intolerable even the touch 
of a light blanket felt like fire to her skin. Even with nothing touching her body, she 
constantly felt a repetitive stabbing sensation that was undiminished.  She was so 
consumed by her pain that she contemplated suicide. 
Lindsay’s parents were at a loss, as many of the patients’ families are. Those 
close to the patient feel desperate and frustrated because they do not know how to 
alleviate the pain, and must watch their loved ones suffer.  Many CRPS patients are 
                                            
1 Groopman, Jerome. "When Pain Remains: What should Patients do when Doctors can't Figure Out 
how to Treat their Suffering?" The New Yorker, 2005, sec. Medical Dispatches.  
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mentally anguished because physicians misdiagnose their condition or disregard it as 
imaginary.  The disparity of the situation, as doctor after doctor cannot offer a 
conclusion as to what is causing the pain, leaves many patients such as Lindsay 
contemplating suicidal to end their distress and misery. 
Fast forward two years and Lindsay is amazingly nearly pain free. She has 
gone back to school and is interacting as a regular teenager again.  Her relief began 
the day she started seeing Schwartzman, a specialist in the area of CRPS, who has 
treated over 5,000 patients with the disorder.  Schwartzman’s use of a controversial 
treatment for CRPS that involves placing patients in a drug-induced coma has 
received international attention.  
When Lindsay’s mother first heard about the controversial treatment, she 
decided it was her only option.  Her daughter had nothing left to live for, and the 
treatment, which is not FDA approved and involves the patient being sent to Germany 
to be placed in a ketamine-induced coma for five days, seemed like the only answer 
left. 
Chronic pain has been studied for the last 150 years, yet neither a single organic 
nor a single psychological cause has been located.  The American Pain Foundation 
estimates that over 50 million Americans suffer from chronic pain and another 25 
million suffer from acute pain after surgery or injury, however health statisticians 
agree that the number is much higher in reality.2  Pain is a complex mechanism which 
doctors and historians have struggled to understand for centuries.  Understanding pain 
                                            
2 Weiner, Richard S. Pain Management: A Practical Guide for Clinicians. sixth ed. CRC Press, LLC., 
2002.  
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is thus an important part of the history of medicine.  It is a global problem, perhaps 
one of the most daunting problems contemporary researchers struggle with.  It is no 
wonder that doctors who research pain are drawn to CRPS, the most painful of all 
painful diseases.   
In the story of CRPS, thus we encounter a historical problem in a contemporary 
setting, where doctors, patients, and the public assume we have a sophisticated way of 
studying pain based on the scientific and technological advancements of the 21st 
century, until faced with an intractable problem.  This intractable pain problem 
manifests itself in patients, human beings who rely on the doctor in the white coat to 
ease their suffering both physically and emotionally.3  However, the fundamental 
relationship between doctor and patient, a relationship structured by strict 
authoritative guidelines over centuries, can be disrupted when investigating and 
treating CRPS.4      
                                            
3 Brandt, Lawrence J. M.D. "On the Value of an Old Dress Code in the New Millennium." Archives of 
International Medicine 163, no. 11 (2003): 1277-1281. The tradition of the physician’s white coat 
dates back to the late nineteenth century.  The white coat demonstrates “scientific validity for their 
treatments and to represent purity and cleanliness: praiseworthy qualities in a healer.”  Today, we 
continue to see this tradition upheld by new doctors as they participate in a rite of passage known as 
the “white coat ceremony”.  It’s practical applications are valid as well such as keeping the physician’s 
clothes underneath clean and so that patients can readily identify the physician.   However, the white 
coat has taken on a different symbolic nature, one that highlights economic and social hierarchies, 
power and authority, and individual value systems.     
4 Banks, Carol and Karen Mackrodt, eds. Chronic Pain Management. London: Whurr Publishers, 
2005. and, Baszanger, Isabelle. Inventing Pain Medicine : From the Laboratory to the ClinicRutgers 
University Press, 1998, and Bountra, Chas, Rajesh Munglani, and William K. Schmidt. Pain: Current 
Understanding, Emerging Therapies, and Novel Approaches to Drug Discovery.  Marcel Dekker, Inc., 
2003, and Carr, Daniel B., John D. Loeser, and David B. Morris, eds. Narrative, Pain, and Suffering. 
IASP Press, 2005, and Caudill, Margaret. Managing Pain before it Manages You. Guilford Press, 
2002, and Dworkin, Robert H. and William S. Breitbart, eds. Psychosocial Aspects of Pain: A 
Handbook for Health Care Providers. IASP Press, 2004, and Jackson, Marni and Meridith B. 
(REVIEWER) Marks. "A Painful Understanding: Pain: The Science and Culture of Why we Hurt." 
Canadian Medical Association. Journal 169, no. 10 (Nov 11, 2003): 1055, and Prithvi, Raj, P., ed. 
Practical Management of Pain. Mosby, 2000, and Sternbach, Richard A. Pain Patients: Traits and 
Treatment. Academic Press, 1974, and, Vertosick, Frank T. Why we Hurt: The Natural History of 
Pain. Harcourt, 2000, and, Warfield, Carol A. and Zahdid, Bajwa H., eds. Principles and Practice of 
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Historians of medicine have shown that the universal human experience of 
pain has undergone multiple understandings.  Judeo-Christian thought used pain as a 
central metaphor to establish if society was good or bad.  Eighteenth century 
physicians “valued pain as a symptom, a sign of the patient's vitality, of the 
prescription's effectiveness” whereas the nineteenth century utilitarian thought 
focused on individual autonomy and strove to rid individuals of pain.5  The 
introduction of opiates and anesthesia to relieve pain offered new positive 
possibilities of surgical treatment for patients.  The development of drugs such as 
morphine, opium, phencyclidine (PCP), and ketamine showed an increasing aim on 
the part of researchers and physicians to develop more precise ways of dealing with 
acute and chronic pain while minimizing side effects.   
In this thesis I explore the history of a neurological disease, Complex 
Regional Pain Syndrome, in order to explain why it is difficult to define, diagnose, 
and treat.  I ask how this disease is shaped by physicians, patients, and medical 
disciplines.  Notably, the diverging fields of neurology and psychiatry throughout the 
20th century left experts in both disciplines vying for authoritative claim over certain 
diseases, while disciplinary lines once again became blurred over other “fringe”6 
diseases.  Furthermore, the dichotomy between organized and unorganized illness is 
the location where relationships within the system of patient health can be analyzed.  
                                                                                                                            
Pain Medicine. McGraw-Hill, 2004, and Weiner, Richard S. Pain Management: A Practical Guide for 
Clinicians. sixth ed. CRC Press, LLC., 2002., R. S. (2002).  
5 Meldrum, Marcia L. "A Capsule History of Pain Management." The Journal of the American Medical 
Association 290, no. 18 (2003): 290. 
6 Price, B. H., R. D. Adams, and J. T. Coyle. "Neurology and Psychiatry Closing the Great Divide." 
Neurology 54, (2000).  
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While pain that can be organized reasserts neat boundaries of the tasks involved in 
pain management from diagnosis to successful treatment, unorganized pain denies 
these categories. 
CRPS fits into a long history of how doctors and historians have studied pain 
and disease.  The history of neurology informs us of how CRPS is studied today, 
where doctors like Schwartzman are an example of how and why people are finding 
new techniques to alleviate pain within a contemporary model of chronic pain 
management and against the backdrop of the universal human experience.  
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CHAPTER 2: AN OVERVIEW OF THE HISTORY OF NEUROLOGY  
Neurologists and neuroscientists who laid the groundwork for the field of 
neurology date back to the seventeenth and eighteenth centuries but “American 
neurology really began during the Civil War, chiefly through the work of S. Weir 
Mitchell and William A. Hammond.”7  The American Civil War resulted in the 
expansion of the field due to the increase of neurological injuries suffered by soldiers.  
These injuries and how to best treat them fueled debates about physiological or 
psychological explanations for shell shock, trauma sustained from warfare.  
The U.S. Army created a new division of Neurology and Psychiatry which 
provided the first institution for studying of soldiers with brain, head, and nerve 
damage. Moreover, American physicians who were investigating these injuries were 
provided with case material for their research, which would appear in scientific 
publications.  This material attracted the attention of the international neurological 
community in the postwar era.  Surgeon General William A. Hammond, who was 
instrumental in institutionalizing neurology in the U.S., created the first American 
institution for neurological investigation and hospital devoted to soldiers and 
neurological injuries, Turner's Lane Hospital in Philadelphia, 18638.   
It was at Turner’s Lane Hospital that Mitchell, appointed by his friend 
Hammond, studied soldiers with a particular neurological condition that Mitchell later 
termed causalgia (Greek for ‘burning pain’).  In 1864, Mitchell published a book on 
                                            
7 Roberts, Charles Stewart. "Weir Mitchell of Philadelphia." Chap. IV, In Clinical Methods: The 
History, Physical, and Laboratory Examinations, edited by H. Kenneth Walker, W. Dallas Hall and J. 
Willis Hurst. Third ed. Butterworth Publishers, 1990.  
8Tyler, K., G. K. York, D. A. Steinberg, M. S. Okun, M. Steinbach, R. Satran, E. J. Fine, et al. "Part 2: 
History of 20th Century Neurology: Decade by Decade." Annals of Neurology 53, no. 4 (2003).  
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his experiences at Turner’s Lane in collaboration with George R. Morehouse and 
William W. Keen titled Gunshot Wounds and Other Injuries of the Nerves.  The book 
included a clinical description of the syndrome and described a soldier who suffered 
from it as “the most amiable grow irritable, the soldier becomes a coward, and the 
strongest man is scarcely less nervous than the most hysterical girl.”9  In 1872, 
Mitchell named the condition causalgia, later termed Complex Regional Pain 
Syndrome in 1994, in his monograph entitled Injuries of Nerves and Their 
Consequences.10  Treatment for causalgia included water dressings and morphine 
injections for soldiers suffering from intense, burning pain.  Mitchell explained 
causalgia as "the most terrible of all the tortures which a nerve wound may inflict."11  
Born in Philadelphia in 1821, Mitchell, like Schwartzman12 attended the University 
of Pennsylvania and Jefferson Medical College.13  
The American Neurological Association (ANA), founded in 1875 by 
Hammond and his colleagues, was the country’s first association devoted to “the 
                                            
9 Mitchell, S. W. Gunshot Wounds and Other Injuries of Nerves. Philadelphia: Lippincott, 1864. 
10Mitchell, S. W. Injuries of Nerves and their Consequences. Philadelphia: J.B. Lippincott, 1872.  
11 Mitchell, S.W, 1872. 
12 As a fascinating aside, Mitchell in the 19th century and Schwartzman in the 21st century are both 
neurologists who worked at the same institutions in the same city, researching the same disease.  
CRPS, a disease spanning over centuries of research continues to remain mysterious to those who 
research it and those who suffer from it.  Recognized in 1870s, why are some physicians unaware of its 
warning signs as it continues to go unrecognized and even unaccepted in clinical medicine? Have we 
come far enough in over a century? 
 
13  "Thomas Jefferson University." Thomas Jefferson University. http://www.jefferson.edu/main/ 
(accessed 5/13/07, 2007).  In 1825, Jefferson Medical College became the first medical college in the 
United States to introduce a system of patient care combined with medical education in the form of a 
clinic.  Jefferson also established the first division of neurology in the country in 1831.  As a whole the 
institution is Thomas Jefferson University, comprised of Jefferson medical College, Thomas Jefferson 
University Hospital, the College of Graduate Studies, and the College of Allied Health Sciences. 
Currently “this academic health center tests and treats 25,000 inpatients and more than 300,000 
outpatients every year, and enrolls 2,600 future health care professionals. Public and private funding of 
Jefferson research exceeds $64 million annually.” 
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cultivation of Neurological Science.”14  At its inception the ANA included thirty-five 
members, who founded the journals related to the therapeutic and theoretical bases of 
neurology, including the Archives of Electrology and Neurology (1873) and the 
Alienist and Neurologist (1880).  The articles published in the Archives of Electrology 
and Neurology emphasized the technical skills unique to the neurologist, and the 
journal portrayed the new concept of the neurologist for the first time as a specialist.15   
In contrast the American Journal of Neurology and Psychiatry (1882) viewed 
neurology as an integral part of general medicine.  The two distinct messages of these 
journals suggest that some neurologists considered neurology as a distinct discipline 
from general medicine and psychiatry while others remained attached to old ties.16  
Neurology would remain in this state of disciplinary vagueness until the mid-
twentieth century.  
In the twentieth century, neurology became an influential and independent 
discipline that witnessed “dramatic changes and advances in virtually every aspect of 
neurology.”17  Advancements in neurophysiology, and the histology and pathology 
solidified the scientific framework of neurology.   
The first half of the twentieth century marked three categories of scientific 
advancements: more precise diagnostic techniques, improved forms of therapy, and 
                                            
14 Goetz, C. G., T. A. Chmura, and D. Lanska. "Part 1: The History of 19th Century Neurology and the 
American Neurological Association." Annals of Neurology 53, no. 4 (2003).  
 
15 Tempus Et Hora: Time and the Hour. Directed by Christopher G. Goetz. 2000, 
http://www.aneuroa.org/html/set-tempus.htm.  
16 Goetz, C. G., T. A. Chmura, and D. Lanska. "Part 1: The History of 19th Century Neurology and the 
American Neurological Association." Annals of Neurology 53, no. 4 (2003).  
17 Tyler, K., G. K. York, D. A. Steinberg, M. S. Okun, M. Steinbach, R. Satran, E. J. Fine, et al. "Part 
2: History of 20th Century Neurology: Decade by Decade." Annals of Neurology 53, no. 4 (2003).  
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improved research techniques.  More important, however, is to notice the scientific 
techniques and advancements that developed at the time and explore “how they 
became incorporated into daily practice.”18   Discovered in 1929 by German 
psychiatrist Hans Berger, electroencephalopgraphy (EEG), records brain waves and is 
helpful in determining neurological conditions such as epilepsy, seizures, and brain 
tumors, 19 “afforded the initial great impetus to clinical neurology.” 20  As 
neurological scientific and therapeutic techniques became more complex, “the need 
for specialized training in medical neurology gradually increased.”21  In the 1930s-
1960 neurology slowly emerged as an independent discipline.  Before this time, it 
was generally known that in order to make a living neurologists had to combine their 
work with a general practice or specialty, or hold a high academic post.  The earlier 
generation of neurologists “was largely limited to the descriptive phases of the subject 
and clinicopathological correlations.”22   The new generations of neurologists 
developed the diagnostic, “therapeutic, rehabilitative, and preventative measures that 
now characterize the field” 23
In the early 1910s, American neurologists debated the value of Freudian 
psychoanalysis and its place in neurology.  Freud believed that discussing the 
                                            
18 Aird, Robert B. Foundations of Modern Neurology: A Century of Progress. New York: Raven Press, 
1994.  
19 Tudor, M., L. Tudor, and K. I. Tudor. “Hans Berger (1873-1941)--the History of 
Electroencephalography.” Acta Med Croatica 59, no. 4 (2005): 307-313.  
20 Aird, Robert B. Foundations of Modern Neurology: A Century of Progress. New York: Raven Press, 
1994. 
21 Aird, 3. 
 
22 Aird, 1. 
 
23 Aird, 1. 
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unconscious causes of mental illness is an effective treatment and his psychoanalytic 
theory, widely recognized in the theory of psychology, “sees mental illness as a result 
of human experience rather than biological errors of the brain and central nervous 
system.”24  It is important to note that while European analysts drew from other 
disciplines such as literature, law, philosophy, and natural science in their discussion 
of psychoanalysis, the U.S. developed psychoanalysis as “an extension of medical 
practices by doctors or psychiatry and neurology.”25
In the 1920’s, medicine experienced a boom in technical innovation, including 
in neurology.  In a mere ten years instruments such as the myelogram, angiogram, 
electroencephalogram, and the electromyogram were all introduced into neurological 
practice.  Although neurology was a division of psychiatry in the 1920’s, an 
endowment from the Rockefeller Foundation to the Boston City Hospital for the 
development of a neurological unit served as a template for other departments of 
neurology in the 1930s.  “Many neurological syndromes had been clinically defined 
and their neuropathologic basis identified” in the 1930s and the elementary 
neurological examination was refined with objective, consistent, and reproducible 
findings.26   
The ANA did not meet until 1946 because of World War II but “the majority 
of neurological publications in the Allied Countries related to war injuries, aviation 
                                            
24Ventura, Thomas. "Psychoanalysis." AllPsych Journal (April 8, 2002).  
25 Ventura, 2002. 
26 Price, B. H., R. D. Admans, and J. T. Coyle. "Neurology and Psychiatry Closing the Great Divide." 
Neurology 54, (2000).  
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medicine, and clinical neurophysiology” during the 1940s.27  “Some of the 
pathophysiological concepts that remain most important in the current practice of 
neurology emerged during the 1950s.”28  For example, C. Miller Fisher described 
carotid thrombosis as a cause of stroke and “intracranial pressure disturbances in 
many disease states became clearer.”29  
In the 1960s, neurologists developed microsurgical techniques and achieved 
the first human heart transplant.  Also, for the first time, the US Surgeon General 
declared that smoking had serious consequences to health and “landmark legislation 
became law and provided insurance for medical care to millions of elderly 
Americans,” which had a profound effect on neurological care for the elderly.30   
The 1970s saw great progress in the areas of clinical neurological work, 
patient care, education, and research where “specific areas of great discovery 
included the basic neurobiological, neurophysiological, neuroimaging, 
neuroimmunological, and neuropharmacological fields.”31  Also, this decade saw 
advancements in treatments for various neurological disorders like Parkinson’s 
disease, stroke, and epilepsy.  It is important to note that Schwartzman, who began his 
training as a neurologist in the late 1960s, published numerous studies on Parkinson’s 
disease throughout the 1980s which may suggest his appetite for researching diseases 
at the forefront of neurological investigation.   
                                            
27 Tyler, K., G. K. York, D. A. Steinberg, M. S. Okun, M. Steinbach, R. Satran, E. J. Fine, et al. "Part 
2: History of 20th Century Neurology: Decade by Decade." Annals of Neurology 53, no. 4 (2003).  
28 Tyler at al., 2003. 
29 Tyler at al., 2003. 
30 Tyler at al., 2003. 
 
31 Tyler at al., 2003. 
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In the 1980s, technological advancements included the computerized axial 
tomography (CAT) scan, magnetic resonance imaging (MRI) scan, positron emission 
tomography (PET), and the single-photon emission tomography (SPECT) scans.  The 
1980s saw widespread clinical use of computerized tomographic (CT) e-ray imaging 
of the brain, and the PET and MRI scans.  DNA sequencing in biology led to the 
1983 discovery of a polymorphic DNA marker associated with Huntington’s disease.  
 By the 1990s there were many therapeutic options for neurological patients 
“further obliterating the image of the neurologist as diagnostician with little 
therapeutic value to offer the patient.32”  Also, a main component of 1990s neurology 
that carries into the twenty-first century is the “application of human genetics to 
neurological diseases.”33  
 
 
 
 
 
 
 
 
 
 
 
                                            
32 Tyler at al., 2003. 
 
33 Tyler at al., 2003. 
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CHAPTER 3: MEDICAL REDUCTIONISM AND HOLISM 
The common description of medicine during the nineteenth and twentieth 
centuries shows that medicine and medical practices became progressively more 
reductionist as biomedicine continued to rely increasingly on laboratory based 
research and new technologies.  This allowed for the investigation of smaller and 
smaller units of organic bodies.  Medical reductionism is mostly characterized by the 
specialization of the medical field and reliance on laboratory practices and technology 
as it is associated with a total emphasis on specific or mass produced cures rather than 
disease prevention.34  Critics, from both within and outside biomedicine, argued that 
this approach ignores patients individual needs, their cultures, and their social 
context.  We will see that neurology has retained a distinct, holistic and 
interdisciplinary view of treatment for patients. 
Jan Smuts coined the term holism in 1926 however the term was not widely 
used during the interwar years.35  Holism is “essentially relational; it constitutes a 
rhetorical claim made in opposition to other approaches that are characterized as 
excessively narrow or reductionist in focus.”36  Holism also includes the overall 
condition of the individual in relation to their environment as opposed to singling out 
                                            
34 Harrington, Anne, Cay-Rüdiger Prüll, George Weisz, Christopher Lawrence, Steve Sturdy, Theodore 
M. Brown, Sarah W. Tracy, et al. Greater than the Parts: Holism in Biomedicine, 1920-1950. Edited 
by Christopher Lawrence,George Weisz. New York: Oxford Univ. Press, 1998.  
35 Anker, Peder. "General Smut's Politics of Holism and Patronage of Ecology." In Imperial Ecology: 
Environmental Order in the British Empire, 1895-1945, 41. Cambridge, Massachusetts: Harvard 
University Press, 2001. 
36 Harrington, Anne, Cay-Rüdiger Prüll, George Weisz, Christopher Lawrence, Steve Sturdy, Theodore 
M. Brown, Sarah W. Tracy, et al. Greater than the Parts: Holism in Biomedicine, 1920-1950. Edited 
by Christopher Lawrence,George Weisz. New York: Oxford Univ. Press, 1998.  
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the status of their organs. Holism suggests “the whole is said to determine the action 
of the parts.”37  
Medical holism has existed since ancient times when the body was understood 
to be as an integral part of its environment.  The body’s state was determined by 
inflows and outflows that suggested its equilibrium and overall health.  As 
institutional medicine grew, its researchers began focusing on increasingly narrow 
subjects.  The interwar years signified “a return to tradition in the early twentieth 
century” brought on by developments within science.38  Early twentieth century 
advancements in bacteriology, medical specialization such as in surgery, and 
pharmaceuticals were encouraged by vast amounts of industrial money flowing into 
medical research while doctors earned great prestige.  Despite medical advances such 
as vaccine therapy and insulin, many researchers nonetheless felt that therapeutic 
advances were lagging behind.  Emphasis on laboratory research and technology took 
a front seat to bedside and clinical practices.  Physicians worried about “the 
bureaucratization of the profession, assembly-line organization of the medical 
workplace, and the destruction of the traditional doctor-patient relationship.”39  
Advocates of medical holism recognized the impersonal structure of biomedicine 
characterized by the “growing depersonalization and dehumanization of medicine” 
where modern life becomes dominated “by technology, bureaucracy, and commercial 
relations.”40  Below I explore the theme of depersonalized medicine exhibited in the 
                                            
37 Harrington et al., 2. 
 
38 Harrington et al., 5. 
 
39 Harrington et al.,5. 
 
40 Harrington et al., 4. 
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contemporary doctor-patient relationship, where tension between experts and patients 
concerning issues of diagnosis or degree of pain, sometimes deterred the CRPS 
patient’s quest for answers to their pain.   
National attitudes towards holism differ among the United States, Great 
Britain, France, and Germany.  Germany in particular has strong ties to holism in 
numerous discourses.  Holism also remains a distinct and important theme among 
German physicians even as Germany held the position of the world’s leading nation 
in conventional science.41     
German neurologist and psychiatrist Kurt Goldstein (1878- 1965) “was 
arguably the most influential and sophisticated German holistic theorist of his 
generation.”42  The era just preceding Goldstein’s (1870- 1900) was marked by “a 
generation of triumphant advance in neurology” and “the mechanistic brain” 
transitioned to an attitude of “leave well enough alone and do not seek to meddle with 
natural processes; it was enough to understand them.”43  
What challenged the mechanistic metaphor in the early nineteenth, especially 
in the brain and the machinist model of the nervous system, was the idea of recovery.  
Increasing evidence supported the new idea that the brain may be able to heal itself.  
It was not “a purely mechanical apparatus operating according to fixed laws of reflex 
association” and showed “the brain as a holistic, dynamic organ capable of adapting 
and reorganizing in the face of trauma.”44  
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The years between World War I and World War II were a crucial turning 
point in reductionism and to the formation of neurology as a distinct discipline when 
“medicine seemed to be registering its greatest triumphs, and condemnations of this 
sort reached new levels of intensity.”45  Those who opposed reductionism from 
within mainstream medicine “attempted to resist what they saw as reductionism and 
excessive reliance on technology.”46  Reaction to reductionism from various groups 
including “constitutionalism, psychosomatic medicine, new-Hippocratic medicine, 
neo- humoralism, social medicine, Catholic humanism…and various forms of 
alternative healing” contributed to what comes to be known as “holistic.”47
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CHAPTER 4: NATIONAL STYLES OF MEDICAL TEACHING: GERMANY, 
ENGLAND, AND THE UNITED STATES 
 
Traditional medical instruction in the nineteenth century most often took the 
form of lecturing to large groups of people.  British schools used teaching 
demonstrations modeled from German and French schools and also taught with 
smaller groups at the patient’s bedside.48  Scandinavian countries followed the 
German ideas of medical practice but eventually gravitated toward the British 
tradition.   
Although the scientific and medical infrastructure of neurology in the U.S. 
was European in origin, as scientific and theoretical advancements in neurology 
developed, the United States blended styles from many traditions and ultimately 
developed a style of its own.49  For example, Brown Séquard, a neurologist who 
studied in Europe and the U.S., crystallized the concept of experimental medicine as 
developed by the French physiologist Claude Bernard.  Although animal 
experimentation can be considered socially controversial, the ANA states “virtually 
every advance in medical science in the 20th century, from antibiotics and vaccines to 
antidepressant drugs and organ transplants, has been achieved either directly or 
indirectly through the use of animals in laboratory experiments.”50  Moreover, 
according to Bernardian ideas, biomedical laboratory experiments “on animals will 
yield significant biomedical truths about humans” and there is no other method “(save 
                                            
48 Aird, Robert B. Foundations of Modern Neurology: A Century of Progress. New York: Raven Press, 
1994.  
49 Aird, 223. 
 
50 American Medical Association. [1988]: The Use of Animals in Biomedical Research: The Challenge 
and the Response. Washington, D.C. 
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immoral and illegal human experimentation) which could yield the same results”51  
This aspect of modern medical practice is especially crucial in understanding the 
advancements in neurology and Schwartzman’s contribution to the study of CRPS.   
We see that it is scientifically essential for modern medical practitioners to 
develop techniques and procedures first conducted on animals and then transfer these 
techniques to the realm of treating and curing the human body.  Thus, it is important 
to survey European models of medical practice that forged the path in what would 
eventually become modern neurology in the United States.  Moreover, it is crucial to 
understand that Schwartzman’s research is international in its scope, practice, and 
impact as he travels and collaborates with German scientists.  Germany’s long history 
of excellence in neurology coupled with a leniency in prescribing large ketamine 
doses, allows for an environment conducive to treating severe CRPS patients.    
The German Tradition 
One progressive feature of German medical teaching was that students could 
transfer from school to school to study under professors who were exceptional in the 
student’s budding field of interest.  Dr. Robert B. Aird, founder of the department of 
neurology at the University of California at San Francisco explains in the following: 
The result was that many German professors became showmen, whose 
lectures and demonstrations, in vying for attention, were featured by much 
declamation, sometimes to the point of bombast.  Their air of authority proved 
inimical to a proper doctor- patient relationship and all too often reduced their 
demonstrations to little more than text book pictures of disease process.52
                                            
51 Hugh LaFollette and Niall Shanks. "Animal Experimentation: the Legacy of Claude Bernard".  
International Studies in the Philosophy of Science (1994) pp. 195-210. 
52 Aird, Robert B. Foundations of Modern Neurology: A Century of Progress. New York: Raven Press, 
1994.  
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This earlier method of medical instruction greatly differs from the more practical and 
modern system of teaching which heralds personal patient communication as a result 
of bedside teaching and close laboratory instruction.   
In order to understand the changing attitudes of neurological teaching in 
Germany, it is important to also understand the country’s enormous social and 
political changes that resulted from two world wars and the Great Depression, 
coupled with scientific advancements.  These issues come to light by illustrating the 
career of Georges Schaltenbrand (1897- 1979). 
 After World War I, Schaltenbrand became known as one of the most 
exceptional neurologists in Germany.  With support from the Rockefeller Foundation 
he earned an appointment at Johns Hopkins Neurological Institute, however with the 
onset of the Great Depression, Johns Hopkins could not fulfill its obligation to the 
institute.  In 1934 Schaltenbrand was instead appointed interim director of the 
Department of Neurology at the University of Hamburg but with the rise of Hitler to 
power, coupled with the fact that German universities were supported by the 
government, many appointments were negated.  Schaltenbrand soon found himself 
ostracized at Hamburg due to his outspoken position against the Nazis.  He was 
fortunate enough to obtain a teaching post in neurology at Wurzburg.   
The postwar years in Germany proved especially tough for leading physicians 
because they were often suspected of cooperating with the Nazis in deadly 
experiments at concentration camps.  This had a demoralizing effect for many 
physicians but Schaltenbrand, a suspect at the Nuremberg trails, was completely 
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exonerated of any involvement with the Nazi Party.  He received “the highest German 
award, the Erb Medal, in 1952.  A festschrift was published in his honor in 1997. His 
neurological institute at Wurzburg, the Kopfklinikum, with his bust in the entrance, 
stands as a monument to his career and accomplishments.”53
The British Tradition 
  The British system of neurological teaching championed bedside teaching.  
This method, exemplified at the National Hospital at Queen Square, London, was 
“the center of neurological postgraduate teaching for the British empire, before World 
War II”54  The British method involves careful consideration of the patient’s history 
as well as the examination where “this in addition to challenging student quizzing 
provided the essentials for understanding each condition as well as the variations and 
complications in individual patients.”55
The emphasis on clinical analysis somewhat overshadowed laboratory 
analysis in the early British period during the first half of the 20th century.  “This was 
exaggerated by the lack of neurological therapy, and the poor economic support of 
medical education in the United Kingdom over the same period.”56  Moreover, 
physical resources at the National Hospital were scarce.  The pathology and surgical 
laboratories were considered technologically inadequate compared to other national 
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trends where “the early archaic x- ray equipment was only finally updated by a gift 
from the Swedish Red Cross following World War II.”57  
At the time, neurologists were still making their livelihood through 
independent practice making it difficult to be fully engaged in clinical work.  “The 
result was that only the most persistent, dedicated, and brilliant neurologists achieved 
success in this strenuous and elite atmosphere.”58   
The Tradition in the United States 
American neurology developed as a specialty in the mid- to late-nineteenth 
century, centered in the cities of Philadelphia, New York, and Boston.  The field 
expanded due to three principal forces: European Medicine and scientific advances, 
the American Civil War, “and the particular American penchant for Medical 
Specialization or Specialism.”59  Before the turn of the century Americans interested 
in advanced specialty training traveled to Paris, London, or Vienna but, 1900 
American neurological hospitals, laboratories, and outpatient facilities attracted 
national and international students and physicians to study medicine in the United 
States.  American neurology, “working simultaneously from the two disciplines of 
internal medicine and psychiatry, sculpted itself with close links to both traditions, 
creating some neurological activities directly out of medical departments, and 
creating others out of psychiatric asylums and other institutes.”60  
                                            
57 Aird, 228. 
 
58 Aird, 228. 
 
59 Goetz, C. G., T. A. Chmura, and D. Lanska. "Part 1: The History of 19th Century Neurology and the 
American Neurological Association." Annals of Neurology 53, no. 4 (2003).  
 
60 Goetz et al., 2003. 
 23
 
Evolving from the British tradition, the U.S. medical practices had progressed 
greatly over the past eighty years, attracting people from all over the world to pursue 
medical study here.  Like other national models, medical teaching in the United States 
was structured by large group lectures with limited resources and facilities for 
teaching and science.  German and American traditions united in the nineteenth 
century where “the more thorough teaching experience provided by the German 
school of medicine was introduced at Johns Hopkins University in 1889 and this 
eventually was followed by Harvard and other leading schools of medicine in the East 
and Midwest.”61
Abraham Flexner, in his 1910 report titled “Medical Education in the United 
States and Canada” called for a new kind of medical training which would provide 
the basis for implementing small group and individual training for students.62  
Following World War II the United States, committed some of its great wealth to 
medicine and created the National Institutes of Health (NIH).  The neurological 
subdivisions at the NIH received good support for both research and training grants.  
European professionals who came to the United States “added to the enrichment and 
expansion of neurology in America.”63
The coming decades challenged the field’s development due to its weak 
infrastructure.  Professorships were well established in European models, whereas 
American neurologists rarely had full institutional facilities to developed and cultivate 
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their specialty.64  Given the predicament of specialization and the inability for 
neurology to stand on its own, “American neurology struggled to realign itself with 
its medical colleagues and at the same time define and protect its unique attributes.”65  
In doing so, neurology and psychiatry regained significant ties which led to the 
foundation of the American Board of Psychiatry and Neurology.  Despite the lack of 
infrastructure, proponents of specialization continued to push toward neurology as an 
autonomous discipline with the creation of “freestanding specialty hospitals and 
services devoted to neurology and controlled completely by neurologists” such as the 
Neurological Institute in New York.       
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CHAPTER 5: THE TRANSITION TO MODERN NEUROLOGY 
  The foundations of neurology and psychiatry were at one time joined “under 
the mantle of neuropsychiatry” where both groups competed for supremacy, however 
psychiatry largely dominated neurology.66  In the last half of the 19th century through 
World War II, neuropsychiatrists such as Meynert, Freud, Kraepelin, and Alzheimer, 
who held positions in neurology and psychiatry, studied the higher order of mental 
dysfunction.  Moreover, diagnostic tests including CSF analysis and diagnostic 
technology such as the EEG contributed to the dichotomy of neurology and 
psychiatry. “Neurology laid claim to those disorders of the nervous system with 
established etiologies and demonstrable anatomic pathology” and “psychiatry pursued 
those disorders of mentation for which there was no visible pathology.”67  
Neurology expanded during World War II when functional neuropsychiatry 
was established in part by Sigmund Freud’s psychoanalytic methods.  The founders 
of modern neurology are from the organic subdivision of neurology.  It is important 
to note that organic neurologists typically combined their specialty with psychiatry 
“prior to the development of an expanded scientific basis for neurology.”68 Although 
scientific developments would allow neurology to blossom as an independent field, 
other issues contributed to the field’s static state.  Aird uses a case history from the 
University of California, San Francisco’s (UCSF) neuropsychiatry department to 
illustrate these complex factors.  Aird explains in the following:    
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The generational gap between older neurophychiatrists, who were often heads 
of teaching departments of neuropsychiatry in medical schools, were steadfast 
in their own disciplines.  In most medical schools during the 1930’s and 
1940’s, the teaching of neurology was handled by neuropsychiatrists who 
served as part-time staff members in small divisions of departments of 
medicine, and so it was at UCSF, where the careers of the head 
neuropsychiatrist had started well before World War I.  Furthermore, the 
integration of teaching from neuroanatomy on through neurology and 
neurosurgery was poor.69  
 
Thus the adoption of new advancements in neurology was often postponed “and as a 
result, the training of the younger generation was frequently inadequate.  At a later 
stage, the independent status of neurology was delayed in many instances by the 
influence and vested interests of the older neuropsychiatrists.”70  
 Recognizing these impediments, the new generation of organic 
neuropsychiatrists demanded that neurology become a separate field from psychiatry.  
It was from this personal history of psychiatry and neuropsychiatry that the American 
Board of Neurology and Psychiatry developed in 1934.  The American Academy of 
Neurology was founded shortly after the end of World War II, but it took far longer 
for the field of neurology to truly step out from the shadow of neuropsychiatry.   
The complex dynamic of neurology versus neuropsychiatry can again be 
illustrated in the UCSF case where neurology remained closely intertwined with 
neuropsychiatry in the Department of Medicine from 1928 to 1952.  “The result of 
this lopsided development was that most of the patients with neurological problems 
were being referred to neurosurgery with the neuropsychiatric group serving as 
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primarily psychiatrists.”71  In its underdeveloped form, neurology lacked resources 
such as hospital beds and full-time staff members.  The situation at UCSF was 
unfortunate “not only in that neurosurgeons rather than neurologists evaluated a high 
percentage of neurological problems, but also in that the follow-through care required 
for neurological patients was not provided.”72  
The relationship between the two diverging fields is also illustrated in the 
history of training requirements.  The Residency Review Committee for Psychiatry 
and Neurology (RCC) “deleted psychiatric training as a mandatory experience for 
neurologists.”73  Today, there is still no requirement for formal psychiatric training in 
neurology residency programs except for a one month psychiatry rotation in pediatric 
neurology.   
The mind/brain perspective and the organic versus functional dichotomy 
between psychology and neurology translated into opposing opinions.  Neurologists 
agreed that psychiatrists knew about the mind but not about the brain and 
psychiatrists recognized that neurologists knew about the brain but not about the 
mind.74  Although research in some disorders by both disciplines such as brain injury, 
organic brain syndromes, and dementia has received collaborative attention, “several 
disorders were allocated to ‘the borderland’ between neurology and psychiatry.  They 
were considered anomalous fringe conditions of minor interest within both 
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disciplines, e.g., temporal lobe epilepsy and Tourette’s syndrome.”75  In addition to 
these borderland conditions, CRPS can also be considered a “fringe” disease.  Both 
disciplines showed an interest in CRPS where neurologists collaborate with 
psychologists in order to determine treatment options for patients so that patients 
receive a holistic method of care.  
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CHAPTER 6: THE “ART OF MEDICINE”76
Not only did technological and scientific advancements lead to the 
development of neurology into its modern form, it is important to consider the “art of 
medicine.”77  The art of medicine in neurology refers to neurology’s balance of 
understanding the nervous system as an integral system for the body as a whole as 
well as “the breadth of perception and understanding in treating the patient as a 
whole. Beyond this, are the challenging mysteries of the mind- brain interrelationship 
and the disorders of emotional expression.”78  The previous discussion of holism 
supports the field of neurology’s awareness of the brain as holistic organ and the 
field’s ability to incorporate a holistic and interdisciplinary view of treatment options 
for patients.  Moreover, neurology, unlike any other field overlaps with a large 
number of other specialties and disciplines such as internal medicine, ophthalmology, 
endocrinology, radiology, and rhinolaryngology.  For all these reasons, many 
neurologists believe that neurology should not be considered a “keyhole” specialty as 
it requires individuals with high intellect as well as the ability to deal with human 
issues while covering multiple disciplines.79  
The previous discussion of holism suggests that all too often neurological 
consultations succeed in their technical diagnosis but fail in the areas of therapeutic 
recommendation and assessing the overall impact of the patient’s disease.  With the 
proper experience, it is the neurologist who has “the knowledge and expertise to aid 
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and integrate the care of the referring physician properly with the support of family 
members to ensure the mobilization of the community resources for the benefit of the 
patient.”80  The neurologist deliberates over the patient’s problems to assess the 
correct plan of action for the patient including specialty referral, preventative 
measures, rehabilitation and follow-up care.   
Neurological rehabilitation requires the utmost care of the physician.  “The 
chronic nature of the disabilities commonly dealt with by this discipline and the 
psychological factors involved in their care demand a high level of patient support 
and physician empathy if rehabilitation efforts are to be successful.”81  Moreover, 
rehabilitation efforts have greatly advanced over the past sixty years.  Before World 
War II, many patients suffering from neurological injuries were not rehabilitated.  
Even after neurology began growing into its own discipline, its infrastructure could 
not support adequate patient referral “which often fell short of a comprehensive 
evaluation, optimal programming, and social service expertise in mobilizing available 
community resources and supportive follow-up care.”82  Aird explains that modern 
rehabilitation in neurology, however, is designed as a more collaborative effort 
stretching over many medical disciplines: 
Depending on the nature of the disability, neurological surgeons, orthopedic 
surgeons, cardiologists, rheumatologists, urologists, and others may be 
involved as well as neurologists.  In addition, psychological studies may be 
required, or the help of brace or prosthetic experts, special nursing care, 
physiotherapists, speech therapists, occupational therapists, social service 
workers, and so forth.  The director of rehabilitation services is responsible for 
an evaluation of each patient’s problems, the organization of an appropriate 
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rehabilitation program, and the coordination effort to achieve it.  Since much 
depends on the patient’s motivation, a continuity of rapport and support is 
essential, which only superior teamwork, headed by a wise director, can 
attain.83  
 
We see that the idea of medicine as an art, not only as a science, is widely applicable 
to the field of neurology.  In the future, it will remain important for neurologists who 
study CRPS to go against reductionist tendencies in biomedicine and instead focus on 
pain therapies which consider the overall wellbeing of the patient.  We will see that 
psychosocial approaches which are incorporated into pain management are helpful in 
treating the ‘whole’ patient.  However, the strengths of both disciplines must be 
applied for successful recovery.  
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CHAPTER 7: SCHWARTZMAN’S CONTROBUTION TO CRPS 
Schwartzman has played a central role in the neurological investigation of 
CRPS since the 1980s.  As an international pioneer in CRPS research and treatment, 
he continues to try to find a cure in the twenty-first century.  It is necessary to 
highlight the career milestones that took Schwartzman from a new doctor in the 
1960s to a leading neurologist in CRPS treatment.  The following section offers a 
brief bibliography of his professional and academic accomplishments as well as 
commitment to CRPS research and treatment. 
Dr. Robert J. Schwartzman, Chair, Department of Neurology of Drexel 
University College of Medicine in Philadelphia, Pennsylvania has researched 
RSD/CRPS for more than thirty years.  As chair, he is committed to Drexel College 
of Medicine’s (DUCOM)84 three strongest areas of research which are motor neuron 
disease, pain, and dementia.  He is a pioneer in RSD/CRPS research and treatment 
and contributed to the founding of RSDSA (Reflex Sympathetic Dystrophy Syndrome 
Association) in 1994 where he continues to serve on the association’s scientific 
Advisory Committee along with nine other doctors from various medical 
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institutions.85  He implemented an RSD clinic at Jefferson Hospital that is now 
located at Hahnemann University Hospital and is board certified by the American 
Board of Internal Medicine and by the American Board of Psychiatry and 
Neurology.86  He received his undergraduate B.A. degree from Harvard College in 
1961 and his Doctor of Medicine degree from the University of Pennsylvania in 
1965.87  He interned at Duke Hospital from 1965 to 1966 and was a Junior Assistant 
Resident in Medicine at Duke from 1966 to 1967.  He did his residency in neurology 
at the University of Pennsylvania from 1967 to 1969 and then became a Clinical 
Associate at the NIH’s Medical Neurology Branch from 1969 to 1971.  He served as 
Chairman of Jefferson Neurology from 1983 to 1995 before becoming a practice 
member of Drexel University in 1995 when he remains today.88   
A preliminary overview of his published literature exemplifies his expertise 
and commitment to the study of RSD/CRPS as well as the future direction of 
treatment for patients.89  Schwartzman’s career followed a course of investigation 
into neurological problems, which eventually led to research on his greatest 
contribution to neurological studies, the study and treatment of CRPS.  Schwartzman 
published his first article in 1967 on “Atypical periodic respiration in an obese 
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patient.”  It was not until 1989 that he coauthored a review study of 200 patients 
suffering from RSD.  The intermediary years before his dedication to the study of 
CRPS consisted of 48 publications detailing research in the areas of but not limited to 
proprioception and vibration sensibility, the sensory cortex and tactile sensitivity, 
atrial myxoma, infantile hemiplegia, and benign trigeminal and facial neuropathy.90  
The following chapter presents survey of Schwartzman’s published literature with an 
emphasis on his contemporary research on CRPS.   
From 1968 to 1972 Schwartzman’s research focused on vibration sensibility, 
thalamic sensory nuclear ablations, and the sensory cortex and tactile sensitivity in 
trained monkeys.  Using a primate model for neurological investigation, “these 
studies were undertaken to determine if the dorsal funiculus is essential for the 
discrimination of vibration sensibility in the monkey.”91  In addition, these studies 
consider the dorsal column lemniscus pathway (somatosensory areas I and II) and 
ablations to these areas to determine the tactile threshold in monkeys.  The results 
indicated that the monkey’s sensitivity to a light touch on the palm “is not 
permanently affected by removal of the opposite SI hand area.”92
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From 1981 to 1982 Schwartzman and colleagues produced three studies on 
cerebral infarction, local cerebral metabolic rate, and local cerebral metabolism.  The 
technique utilized in a 1982 study evaluated “the functional anatomy of the entire 
central nervous system and may be helpful in understanding the mechanisms of the 
methylphenidate-induced stereotypy.”93    
Five studies from 1983 to 1992 indicate an almost decade focus in Parkinson’s 
disease research and its effect on the central nervous system.94  Another study 
“Neuromelanin: a role in MPTP-induced neurotoxicity” focused on 
Methylphenyltetrahydropyridine (MPTP), which “selectively destroys melanin-
containing neurons in the substantia nigra of humans and other primates” resulting in 
clinical symptoms of Parkinson’s disease.95  The study uses Chloroquine, a drug 
which blocks MPP+ binding to neuromelanin, can protect monkeys from MPTP 
neurotoxicity.”96  The study found that intervening in the intracellular interacting of 
MPP+ with neuromelanin with chloroquine may protect against the disruptive effects 
of the neurotoxin. 
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In 1987 Schwartzman published a study titled “Reflex sympathetic dystrophy. 
A review” where he describes the syndrome and its relation to nerve injury.  
Therapies for treating RSD at the time were “directed toward blocking the 
sympathetic innervation to the affected extremity, in conjunction with physical 
therapy.”97  In  addition, theories proposed to explain the pathophysiology of reflex 
sympathetic dystrophy include “‘reverberating circuits’ in the spinal cord that are 
triggered by intense pain, ephaptic transmission between sympathetic efferents and 
sensory afferents, and the presence of ectopic pacemakers in an injured nerve.”98   
A 1989 study by Schwartzman and colleagues titled “Bilateral 
cingulumotomy in the treatment of reflex sympathetic dystrophy” presented a 27- 
year-old female RSD patient described at her preliminary exam as “an overweight 
female sitting naked on the side of the bed” who received a bilateral cingulumotomy, 
or creating lesions on the brain which may relieve pain.99  The procedure consisted of 
“circumscribed lesioning of the dorsal anterior cingulated cortex (dACC), for the 
treatment of intractable chronic pain disorders.”100  Based on the hypothesis that “the 
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experience of pain is influenced by its emotional interpretation,” “cingulumotomy has 
been used to treat a variety of neuropsychiatric illnesses and intractable pain 
associated with cancer, phantom limb pain, post-therapeutic neuralgia, and thalamic 
disease.”101    
The decision to treat the patient with cingulumotomy resumed “after a 
meeting between Thomas Jefferson University Hospital Ethics Committee and 
representatives from Neurosurgery, Neurology and the Anesthesia Pain Service.”102  
The patient suffered an injury to her right arm resulting in “severe pain and grotesque 
dysmorphic changes.”103  After a below-elbow amputation of her right arm the pain 
spread throughout her entire body so that the patient was wheelchair bound and could 
not tolerate clothing, bathing, or a light touch.  Following the first procedure the 
patient was relieved of most of her pain so that putting on clothes and bathing were 
tolerable tasks, however the pain returned after one month.  In light of encouraging 
results from the first operation, doctors performed the cingulumotomy again, this time 
applying “permanent cingulate lesions.”104  The patient reported tolerable discomfort 
after the surgery yet “refused rehabilitation and left the hospital against the advice of 
her attending neurosurgeon.”105  The patient was readmitted after a year where she 
underwent repeat cingulumotomy. The study describes the patient’s results from this 
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cingulumotomy as “although the patient’s lower extremity edema markedly improved 
and she appeared to be in less physical distress immediately following the operation, 
she reported no change in her symptoms.”106  The authors then describe the end 
stages of her treatment where “eight weeks following the cingulumotomy the patient, 
frustrated by her lack of improvement, again left the hospital against medical 
advice.”107   Despite encouraging short term results from repeated cingulumotomies, 
the treatment did not achieve long term pain relief for the patient.  
A 1990 study by Schwartzman entitled “The movement disorder of reflex 
sympathetic dystrophy” discussed 43 patients with RSD “who manifested 
abnormalities of movement.”108  The interest in studying movement disorders in RSD 
patients rested on the hypothesis that “these motor sign and symptoms may precede 
other manifestations of the illness by weeks or months.”109  It is generally known that 
early diagnosis is beneficial for the effective treatment and positive outcome of pain, 
which relief may come from “intense sympathetic blockade or sympathectomy,” 
destroying nerves in the sympathetic nerve trunk.110   
In 1991, Schwartzman measured blood flow and limb temperature in eight 
clinically staged RSD patients and eight healthy control subjects.  Using doppler 
fluxmetry to measure blood flow, the study found that the affected limbs of patients 
with reflex sympathetic dystrophy had significantly increased blood flow during the 
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Valsalva maneuver, a test helpful in diagnosing nerve damage, and cold pressor test, a 
test which measures cardiovascular health and blood pressure. But blood flow 
decreased in normal controls.111 Also in 1991, Schwartzman published a study which 
investigated cutaneous ulcerations and reticulate hyper pigmentation, two types of 
skin lesions, as important aspects to the study of RSD.112  In 1992, Schwartzman 
discussed “Reflex Sympathetic Dystrophy and causalgia” which is related to the onset 
of inflammation in the later stages of RSD.113  Upon further investigation of 
cutaneous manifestation in RSD patients, Schwartzman performed another study by 
observing “RSD-related inflammatory and bollous lesions in nine patients with active 
RSD.”114  The study concludes that “skin disease in RSD is more diverse than 
commonly appreciated and includes severe edema, inflammatory lesions, and a 
nonimmune bullous eruption.”115  Also in 1993, Schwartzman’s study “Reflex 
Sympathetic Dystrophy” addresses the five components of RSD, pain, edema, 
autonomic dysfunction, movement disorder, and trophic changes; injury sites, nerve, 
plexus, or soft tissue; and stages of the disease.116   
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In 1995, Schwartzman performed a study on 51 patients suspected of having 
RSD.  Using magnetic resonance (MR) imaging the study confirmed that 45 of the 
patients had RSD.  Based on RSD criteria, if the MR imaged showed skin thickening 
or thinning, soft-tissue enhancement, muscle edema, and muscle atrophy, “it was 
believed that the patient had MR imaging of RSD.117  The study concluded “MR 
imaging was beneficial in the demonstration of soft-tissue abnormalities in patients 
with RSD. MR imaging may also helpful in diagnosing stages of RSD, particularly 
stages 1 and 3.”118  In 1996 Schwartzman performed a study on the impact of RSD on 
lower urinary tract function.119
In addition to researching physiological explanations for CRPS, Schwartzman 
is also concerned with psychological aspects of CRPS.  A 1998 study titled 
“Personality Assessment of Patients with Complex Regional Pain Syndrome Type I” 
addresses the controversy surrounding the “significant comorbidity of CRPS with 
psychiatric symptoms, especially depression, but it has been debated whether these 
symptoms are the result or the cause of this debilitating disease.”120  The study 
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compares CRPS type I patients and patients with chronic lower back pain from disc-
related radiculopathy (DDR) to determine “whether patients with CRPS are 
psychiatrically different and/or more disturbed than other chronic pain patients.”121  
The study did not find significant psychiatric differences between CRPS patients and 
DRR patients, however information on personality traits of pain patients may prove 
useful in treatment design to that researchers can understand “how much a pain 
patient suffers.”122  
In 1999, Schwartzman published a comprehensive study on posttraumatic 
neuropathic pain syndromes as a particularly difficult clinical problem where “pain is 
clearly one of the most daunting problems of modern medicine.”123  The study 
provides a detailed description of the three stages of CRPS II and II as well as the 
disease’s five major symptoms.   
In a 2000 editorial “New Treatments for Reflex Sympathetic Dystrophy” 
Schwartzman illustrates the physical progression of CRPS in patients.  In addition, 
Schwartzman supports the use of spinal chord stimulation and bolus injections of 
intrathecal baclofen, a GABA- receptor agonist (type B) as possible treatments for 
CRPS type I.124  In 2001, Schwartzman and his German colleagues Thomas R. 
Kiefer, MD and Peter Rohr, MD published “Neuropathic Central Pain: epidemiology, 
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etiology, and treatment options.”  The premise of the paper relies on the concept of 
nociceptive central pain:  
Nociceptive central pain is an emerging concept.  It is well established that 
direct injury to the brain or spinal cord may be followed by pain but it is not 
generally realized that damage to peripheral nociceptive nerve endings in soft 
tissue, plexuses, or the nerves themselves also causes nociceptive central 
pain.125   
 
The study maintains that there is a lack of data on nociceptive pain in relation to 
diseases like radiculopathy, inflammatory peripheral conditions, and CRPS “however, 
because of the common nature of the underlying causes, there may be patients who 
have this problem.”126  A later discussion will illustrate how diseases with similar 
symptoms often go undiagnosed or misdiagnosed by physicians.  Some specific 
illnesses under the umbrella of chronic pain are Repetitive Strain Injury (RSI), 
Chronic Fatigue Syndrome (CSF), fibromyalgia (FM), and CRPS.  
Based on a study by Rajkumar et al., (2001) which reported “an unexpected 
improvement and near resolution of reflex sympathetic dystrophy in a woman with a 
3-year history of the disorder,” Schwartzman performed a study of 42 long-standing 
CRPS patients, who were unsuccessful in previous treatment interventions, and 
treated them with thalidomide.127  Thirty-one percent of patients improved in their 
condition approximately four to six weeks following treatment.  The study found that 
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“having CRPS for an extended period does not preclude a significant beneficial 
response to thalidomide therapy.”128
In 2005, Schwartzman published a study “Multi-day low dose ketamine 
infusion for the treatment of complex regional pain syndrome”.  Based on literature 
that “supports the effectiveness of ketamine in blocking central sensitization through 
its effectiveness on the NMDA receptor,” the study evaluated a 10-day, low-dose 
ketamine infusion of patients “who have failed conservative treatment.”129  The 
results indicated “a four-hour ketamine infusion escalated from 40-80 mg over a 10-
day period can result in a significant reduction of pain with increased morbidity and a 
tendency to decreased autonomic dysregulation.”130
In 2007, Schwartzman Kiefer, Rohr, and other colleagues published their first 
study on the use of ketamine as a treatment for CRPS titled “The neurocognitive 
effects of 5 day anesthetic ketamine for the treatment of refractory complex regional 
pain syndrome” with an objective “to evaluate the physical, neurocognitive, and 
emotional effects of extended treatment with anesthetic doses of ketamine in 
refractory CRPS I patients.”131  Nine of Dr. Schwartzman’s patients (eight females) 
were allowed to undergo treatment in Germany with the approval of the Institutional 
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Review Boards of the University Hospital of Tuebingen and the Teaching Hospital 
University of the Saarland in Saarbruken, Germany.  The ketamine dosage included 
levels of 250-300 ug/dl for at least 4.5 days where “This level of treatment results in a 
medically induced coma.”132  The patients received a neurophysiological evaluation 
before their treatment and again six weeks after their treatment to assess “intellectual 
and academic abilities, executive functioning/processing speed, attention, learning 
and memory, and motor functioning.  Mood/affect and personality were also 
evaluated.”133  The encouraging results of the experiment show that by the six week 
marker of deep ketamine therapy, patients had effective relief of pain “and there were 
no adverse cognitive effects to extended treatment with deep ketamine infusion.”134   
A 2008 publication by Schwartzman, Kiefer, Rohr, and other colleagues titled 
“A Pilot Open-Label Study of the Efficacy of Subanesthetic Isometric S(+)-Ketamine 
in Refractory CRPS Patients” focused on “a subgroup of CRPS patients” who 
“remain refractory to all standers thereapies.”135  The four patients chosen for the 
study were subjected to “continuous S(+)- keramine-infusions, gradually titrated (50 
mg/day-500 mg/day) over a ten day period.”136   
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Despite the success of the 2007 study, patients showed no reduction of pain after the 
ten day treatment.  However, the ketamine dosage showed no relevant side effects, 
thus leaving open the possibility of further investigation of this extended treatment. 
As we have now seen, Schwartzman’s career followed a course of 
investigation into neurological problems, which eventually led to research on his 
greatest contribution to neurological studies, the study and treatment of CRPS.  
Schwartzman’s research in the 1990s focused on symptoms of CRPS such as 
movement disorder, blood flow, limb temperature, cutaneous ulcerations, skin 
lesions, inflammation, and edema.  By 2000, his focus shifted away from research on 
traditional CRPS treatments as he investigated bilateral cingulumotomy, thalidomide, 
and ketamine as possible new treatments for severe and refractory CRPS patients. 
Today, his research favors the drug ketamine, long used to treat chronic pain, as the 
answer to combat pain in his CRPS patients.  Although Schwartzman achieved 
advanced research on CRPS at universities where he obtained his education and 
furthered his career, including institutions such as Duke University, University of 
Pennsylvania, Thomas Jefferson University Hospital, and Drexel College of 
Medicine, it appears as though the bulk of his future research will be conducted 
overseas where he has strong academic ties to colleagues and the University of 
Tübingen, Germany.   
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CHAPTER 8: PAIN IN THE NECK 
Schwartzman’s research over the last thirty years has brought us into a 21st 
century, and new understanding of CRPS.  His accomplishments, along with other 
pain researchers, inform leading members of the neurological community and also the 
lay person’s understanding of CRPS and what can be done to diagnose and treat it.  
The following section characterizes the recent perception of CRPS, both medically 
and socially.  
Complex Regional Pain Syndrome is a neurological disease characterized by 
chronic, severe, burning pain; hyperesthesia, soft tissue swelling; dystrophy; 
hyperhidrosis; vasomotor and sudomotor instability; joint stiffness and patchy 
osteoporosis.137  Formerly known as Reflex sympathetic dystrophy (RSD) and 
causalgia, CRPS types one and two were renamed in 1994 by the International 
Association for the Study of Pain.138  Type one (CRPS1) occurs in the absence of a 
known nerve injury and type two (CRPS 2) involves injury to a major nerve.139  For 
patients with the disorder, a mild trauma such as a bee sting or twisted ankle can 
cause the nerves to misfire, sending inappropriate and intense pain signals to the 
brain.  Following a noxious event, “additional abnormalities including edema and 
changes in skin color, temperature, and sudomotor activity . . . all appear to be out of 
                                            
137 Dunn, Debra G. “Chronic Regional Pain Syndrome, Type 1: Part II.” Association of Operating 
Room Nurses. AORN Journal 72, no. 4 (Oct, 2000): 643.  
138 Pappagallo, Marco M. D. and Rosenberg, Andrew D. M.D. "Epidemiology, Pathophysiology, and 
Management if Complex Regional Pain Syndrome." Pain Practice 1, no. 1 (2001): 11-20.  
139 Groopman, Jerome. "When Pain Remains: What should Patients do when Doctors can't Figure Out 
how to Treat their Suffering?" The New Yorker, 2005, sec. Medical Dispatches.  
 47
 
proportion with the physical damage” sustained in the initial injury.140   Five to six 
million people in the United States are estimated to have CRPS1 and pain is the 
hallmark of the condition which outranks cancer as the most painful disease, based on 
the McGill Pain Index.141
The complex nature of CRPS is an arduous challenge for both physicians and 
affected patients.  CRPS is often diagnosed as a psychosomatic disease and “is poorly 
understood and is often not recognized clinically.”142  Few physicians are familiar 
with the disease and some maintain that the disease is a psychiatric condition where 
“patients with this were often dismissed as being ‘neurotic,’ ‘self-serving,’ or 
‘somatizing,’.”143  Moreover, Anne Louise Oaklander, assistant professor of 
anesthesiology and neurology at Harvard Medical School, “believes that many cases 
of RSD are ‘iatrogenic’ -- inadvertently caused by doctors -- and arise after minor 
operations.”144  She maintains that it is not a disease where a person can minimize 
risks and “there is no mammography that you can perform preventively.”145  The 
disease can happen to anyone and “virtue does not protect you.”146 That is, a person’s 
moral excellence or goodness is not enough to keep them away from harm.  It is 
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important to note that medicine, disease, and treatment are not always qualified in an 
‘objective,’ scientific rationale, but rather understood in terms of subjective, non-
medical, and sometimes arbitrary senses.  The notion of virtue as it is incorporated 
into medical explanations of disease is one that assigns judgments, especially blame 
to different groups in particular, patients.  Doctors, patients, and the public partake in 
a sort of blame scale for diseases where patients are seen as having varying amounts 
of responsibility for their condition.  This is why hearing a story about a smoker who 
died of lung cancer is seemingly less tragic than someone who never smoked a day in 
their life yet died of the same disease.   
The average CRPS patient sees eight to ten doctors before a diagnosis is 
made.147  Medical testing is not available to diagnose CRPS thus the lack of certainty 
for diagnosis “raises doubts in the eyes of doctors and the people that are looking for 
hard lab evidence or good imaging confirmation.”148   And desperate patients are 
turning to new, often unapproved drugs and treatments to manage the disease.   
The cause and symptoms of CRPS remain mysterious, however, patients do 
respond to treatment options.  Treatment is difficult to implement due to the 
individualistic nature of the disease149 even though “treatment guidelines were 
published in 1998 and updated in 2001 that addressed the need to treat the 
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physiological and psychological aspects of CRPS.”150  Pain specialists use a multi-
disciplinary approach to treat CRPS, drawing from different therapeutic genres such 
as pharmacotherapy, nerve blocks, physiotherapy, psychological treatment, 
neurostimulation or intrathecal therapy.151  Importantly, “patients suffering from 
CRPS need to undergo a thorough and comprehensive evaluation so that an 
individualized treatment plan can be initiated.  Treatment usually involves a long-
term patient-physician relationship, requiring initiating a medical plan, reevaluation, 
and likely repeated adjustments of the treatment plan.”152    
Doctors may choose to treat the symptoms of CRPS from about twenty types 
of drugs and procedures “none of which have been approved by the Food and Drug 
Administration (FDA).153  While the FDA approves drugs used for specific practices, 
physicians also have the authority to use these drugs as they see fit.  Other specific 
treatments for CRPS include sympathctomy, physical therapy, nerve stimulators, 
trigger point injections, acupuncture, tourniquet effects, and placebo effects.  As with 
many other diseases treatment options are presented in a hierarchical approach where 
the lesser invasive options are tried and evaluated first before attempting more 
invasive treatments such as nerve blocks.  There is disagreement between 
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professionals about which kind of treatment works best.154  As of 2000, 
sympathetomy is considered a last resort treatment due to surgical invasiveness and 
long-term failure rate of pain relief (71% in a 10 year period).155  And “some 
surgeons do not advocate the sympathectomy procedure because long term results in 
general, can be disappointing.”156   
Recently, a new treatment was added to the list of pain therapies for CRPS.  
Dr. Schwartzman is treating CRPS with the drug ketamine, an anesthetic that blocks 
pain receptors in the body.  The treatment is given to patients in small doses 
intravenously for two to five days at Drexel’s outpatient facility.  Ketamine is shown 
to significantly reduce pain for three to six months.157  Dr. Schwartzman is the only 
doctor in the United States who is approved by the FDA and IRB to administer 
ketamine intravenously continuously for two days.158  A ten-day outpatient procedure 
with a waiting list of 1,200 people is being tested in a controlled experiment.  The 
FDA has approved this trial however it is awaiting approval by Drexel’s institutional 
review board. 
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  Dr. Schwartzman has also sent of his most extreme CRPS patients to 
Germany for a cutting-edge procedure.159  The experimental “and radical approach to 
the disease” subjects the patient to a five day ketamine induced coma while sustained 
by a ventilator.  The procedure costs 30,000 dollars and in some cases patients must 
use fund-raising to cover the cost of the treatment.160  Dr. Schwartzman likens the 
procedure to a computer where “for five days we turn your computer off so you’re 
not having any pain.  When the brain is turned back on, the system is rebooted.”161  
The use of metaphor to describe the brain and its functions has been an important 
concept for researchers.  In early brain studies the brain was described as a blank slate 
or book.  Nineteenth century researchers tailored brain metaphors to new technologies 
such as the steam engine.  We continue to relate brain metaphors to new, cutting-edge 
technologies like the computer.  
The coma treatment now used to treat the most severe cases of CRPS grew out 
of research in Germany where ketamine is used to treat phantom limb pain syndrome 
(PLP).  Phantom limb pain is defined “as pain that is localized in the region of the 
removed body part, after the amputation of the limb.”162  PLP manifests its self as 
postoperative pain, treated by analgesic drugs, and chronic pain.  There are many 
theories regarding the origin of phantom pain.  Triggers for PLP may be located in the 
nerve endings, spinal chord, and brain, none of which can fully explain the 
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persistence of phantom pain.  Yet, there is a link between studying CRPS and PLP 
because the same treatments such as sympathetic nerve blocks have been applied in 
both cases.   
Interestingly, the German team’s ketamine procedure was accidentally carried 
over to CRPS treatment.  A patient suffered severe trauma from a car accident and 
doctors had to induce a coma to protect the patient’s brain.  “When they brought the 
patient out of the coma, the chronic pain was gone.”163  Incidentally, this patient had 
CRPS which predated the accident.  As the German doctors “became confident 
enough in the new approach to begin talking about it informally at international 
meetings, Dr. Schwartzman began referring patients who had tried and failed every 
other treatment.”164      
In collaboration with German anesthesiologists, Ralf-Thomas Kiefer and Peter 
Rohr, Schwartzman learned how to apply the ketamine treatment for patients 
suffering from phantom limb pain and applied it to patients with CRPS.165  His role in 
the coma treatment includes patient diagnosis and patient selection to send to 
Germany.  As of last year thirty patients have been treated in Germany led by doctors 
Kiefter and Rohr at Eberhard- Karls University in Tuebingen.  Currently ten out the 
thirty coma patients “have experienced complete and permanent remission.”166  
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Specifics about the treatment include “bolus injections of ketamine (0.5 mg/kg) and 
midazolam (2.5-5mg) until deep sedation is reached.  Therapy is maintained with 
infusions of ketamine (3-7  mg/kg/h) over five days.  On the fifth day infusions are 
slowly tapered.”167   
Schwartzman, Kiefer, and Rohr have collaborated on two meeting abstracts; 
however, one co-authored paper on the results in Germany has been rejected by a 
journal but has been resubmitted to another journal.  Schwartzman states “we’re 
going to have a hell of a time getting it published.  The journal editors want a double-
blind controlled series.  You can’t do that with coma.”168  Side effects of the 
treatment include hallucinations, flashbacks, and memory loss.  Major concern about 
the treatment revolves around risks from the coma itself where complications may 
include “susceptibility to pneumonia, blood clots, and stroke.”169   
The ketamine coma treatment has evoked responses from medical experts, 
patients, and institutions.  Dr. Anne Louise Oaklander feels there is not enough 
research on ketamine treatment to support its effectiveness when considering the 
risks.170  Thirteen patients who have undergone the treatment in Germany have had 
cognitive testing; the results show no loss of brain function.  Despite the severity of 
the disease and it’s equally severe ketamine coma treatment, this therapy is not a 
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cure.171  Ten patients remain completely relieved of pain however the treatment is not 
available in the United States.  CRPS sufferer Cynthia Tousiant states “it says a lot 
about this disease that we are willing to be put into comas.”172
Based on the risks associated with the treatment “The medical- ethics 
committee at Drexel University has not granted Dr. Schwartzman permission to treat 
patients to the point of coma.”173  Although the FDA has taken steps in favor of 
ketamine treatment, with the approval of the two-day infusion while the patient is 
awake “Schwartzman holds little hope that the coma procedure will ever be allowed 
here.”174   
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CHAPTER 9: THE PAIN INVESTIGATION 
In the late nineteenth century, neurologists developed more diagnostic tools to 
define the characteristics of pain patients.  Meldrum explained in the following: 
While alienists and psychoanalysts found these disorders useful clues to 
mental or emotional disease. This disciplinary shift was further supported by 
the development of neurophysiological evidence that supported the idea of 
"true" pain as a direct, proportional response to a specific noxious stimulus.175   
If researchers categorized some types of pain as true pain, there is justification for the 
opposite to exist as well which is untrue or false pain.  This dilemma is especially 
problematic to CRPS researchers and patients where the disease’s primary symptom 
“is a severe neuropathic pain state that is often disproportionate to the initial trauma,” 
a contradiction to the definition of pain.176   
Keefe et al. discuss psychological approaches for patients in pain and also the 
shortcomings of the traditional biomedical model of pain.  For over thirty years, 
psychologists have been developing approaches to assess and treat chronic pain that 
arises in patients with diseases like lower back pain, cancer, migraines, and arthritis.  
The rationale for incorporating psychological approaches into disease related pain 
management is because the traditional biomedical model has a number of significant 
limitations.  First, the biomedical model assumes that the amount of pain “is 
proportional to the degree of disease activity or tissue damage” however “research 
has shown that the amount of pain reported is very often not proportionate to 
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underlying evidence of disease activity.”177  Second, the model assumes that medical 
or surgical interventions will reduce or eliminate pain.  For example, a patient that has 
a malignant tumor that is causing pain will have less pain if the tumor is removed.  
However, research shows that some women who have received a mastectomy 
experience phantom limb pain after surgery.  Thus, the model does not account for 
these inconsistencies.   
Most important to Keefe’s analysis is that the traditional model of disease- 
related pain ignores psychological aspects such as anxiety or depression “and are not 
considered to play a direct role in the pain experience.”178  Also, because the 
dominant biomedical model considers pain as a symptom of an underlying pathology 
and most medical professionals adhere to its protocol, the traditional model presents 
barriers that interfere with medical pain management.179  A study by Ward et al. 
(1993) identified eight barriers on the part of patients dealing with their pain.  “These 
barriers include fear of addiction, concerns about tolerance, concerns about side 
effects, concern that pain means disease progression, fear of distracting one's 
physician from treating the disease, fear of injections, fatalism, and the belief that 
‘good’ patients do not complain about pain.”180  Barriers five and eight (as previously 
listed in that order) show that patients “may be reluctant to admit that psychological 
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factors such as stress or mood influence their pain because of fear that their pain may 
be dismissed as psychological and not treated as real, physical pain.”181  This study is 
particularly important to CRPS research where patient’s disease often coincides with 
psychological barriers.  Since pain management includes a multitude of disciplinary 
overlap, it is important to discuss the social construction of medical knowledge and 
illness. 
While the social construction of medical knowledge “deals with the ways of 
knowing that are based on the dominant biomedical framework, contemporary moral 
and ethical views, the socialization of medical providers (especially physicians), the 
professional and institutional practices of the health care system, and the larger social 
structures of society,” the social construction of illness is concerned with the “lay 
experience of illness”.182  Here, we are concerned with both frameworks and also the 
categories established by actors who participate in defining these frameworks.  
Relevant actors include scientists and researchers, government institutions, medical 
professionals, pharmaceutical companies, insurance companies, and patients.  These 
actors establish a knowledge base and belief system about pain, diagnosis, and 
disease.183  The forces in both of these frameworks sometimes collide in chaotic 
fashion in the system of patient health, which includes all individuals and actor 
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categories that influence treatment and treatment options for patients.  CRPS is an 
example of this collision where the system of patient health goes awry.     
When the validity of pain is in question “physicians are confronted with what 
is often an ‘unorganized illness’, an agglomeration of complaints and symptoms 
which may be unclear, unconnected, and mysterious.  Their job is to understand and 
interpret that material in order to arrive at an ‘organized illness’.”184   Chronic pain 
can be considered an unorganized illness.  Illnesses such as chronic fatigue syndrome, 
fibromyalgia, sick building syndrome, and gulf war syndrome share similar 
unknowns as with CRPS.  These conditions exhibit pain symptoms with an 
unexplained origin.185  What happens to the system of patient health when illness 
defies organization?  We can analyze relationships within the system of patient health 
by studying the dichotomy between organized versus unorganized illness. While pain 
that can be organized reasserts neat boundaries of pain management from diagnosis to 
successful treatment, unorganized pain denies these categories.  
The process of diagnosis and treatment functions both at micro and macro 
levels.186  The micro level includes patient experience, social and family 
relationships, and personal choice regarding treatment.  The macro level includes the 
constructions of medical knowledge, biomedical framework, political involvement or 
regulatory institutions, economics, and health care systems.  The two levels provide a 
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framework for patient health and how it is understood within the constructed context.  
Furthermore, these institutions define the ways in which diseases are categorized, 
experienced, interpreted, and managed. 
Medical professionals provide the first link in the system of patient health by 
assigning meaning to pain via the system of diagnosis.  The patient presents a certain 
set of symptoms to the physician.  Based on the patient’s symptoms or medical test 
results, the physician offers a diagnosis.  From this point treatment options are 
considered by both the physician and patient and a course of action is clearly in 
effect.  As the investigation of the patient’s pain begins, the patient can be seen as 
“good” or “bad” by medical practitioners.187  Good pain follows the system of 
diagnosis to its conclusion.  The cause of pain is identified and diagnosed, treatment 
proves successful, and the body is repaired or cured.  Brown states “diagnosis 
represents the time and location where medical professionals and other parties 
determine the existence and legitimacy of a condition.”188  Only after diagnosis can 
subsequent action for managing the illness implemented.   
Diagnosis offers legitimacy and can function as a control mechanism for both 
patients and medical professionals.  Patients accrue legitimacy in their illness and 
perhaps can become exempt from personal or social blame.  Professionals remain in 
their authoritative role “by mastering the knowledge of the problem at the individual 
                                            
187 Eccleston, Chris, Williams, Amanda C De C., and Wendy Stainton Rogers. "Patients' and 
Professionals' Understandings of the Causes of Chronic Pain: Blame, Responsibility and Identity 
Protection." Social Science & Medicine 45, no. 5 (Sep, 1997): 699.  
188 Brown, Phil. "Naming and Framing: The Social Construction of Diagnosis and Illness." Journal of 
Health and Social Behavior (1995): 34.  
 60
 
care level.”189  The way in which “good” pain is diagnosed and treated reasserts the 
categories of patient health and the system is kept in tact. 
 Alternatively to “good” pain, “bad” pain caused this system to break down 
when an initial explanation for pain cannot be identified.190  Bad pain follows a circle 
of distrust as “both patient and practitioner gradually come to treat the investigation 
with suspicion.”191  The pain investigation puts the patient and practitioner at odds 
with one another as each questions the other’s legitimacy.  The patient is seen as 
making up the pain, desiring attention, or having a psychosomatic disease.192  
Conversely, “for the patient it [lack of diagnosis] may mean viewing the practitioner 
as incompetent or uncaring.”193  
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CHAPTER 10: PATIENT EXPERIENCES: WHAT DOES YOUR PAIN 
MEAN TO YOU? 
 
Patient experiences serve as an excellent lens in determining common themes 
and experiences by those who suffer from chronic diseases such as CRPS.  Medically 
unexplained symptoms prove problematic for medical practitioners when they 
attempt to define, diagnose, and treat patients.  Moreover, the inability to distinguish 
between diseases with similar symptoms creates confusion among medical 
practitioners and patients.  This section offers a multifaceted, theoretical discussion of 
what pain means to patients as well as issues of autonomy, responsibility, blame, 
stigma, and legitimacy.  
Eccleston et al. argue that themes of blame, responsibility, and identity plan an 
important part in the doctor- patient relationship.  Sixty chronic pain patients and pain 
professionals rated the importance of pain themes on a scale of -6 to +6, the higher 
the number the more the person agrees with the theme.  Patients attempt to legitimize 
their pain as they now define themselves as a person suffering in physical pain.  
Importantly, patients rated “there is always a physical cause of chronic pain even if 
doctors cannot diagnose it,” at a +6.194  Eccleston et al. state “the dominant theme of 
this account is the contested reality of the pain and the conviction that it always has a 
physical origin.”195 There is disparity between how patients see chronic pain as 
opposed to how professionals see chronic pain.  Professionals rated the idea “for 
some people chronic pain becomes a way of life” at a +6.196  Professionals rate 
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physical explanations of pain a lower rate than patients.  The difference in opinion of 
the origin of pain allows each group to blame one another when explanation and 
resolution cannot be reached.  The authors state “The patient career of chronic pain is 
largely one of protecting one’s legitimacy as a person and as a sufferer . . . by shifting 
blame back to the medical profession.”197  The authors take the notions of blame and 
responsibility further regarding medical professionals.  In the professional’s case , 
there is “a resistance to an ownership of this total responsibility.198  The 
undiagnosible . . . challenges the power of medicine with repeated contrary 
evidence.”199
    Johansson et al. performed a study on chronic pain in women.  This study 
focused on patient pain and aspects of pain that link body, gender, and society.  
Performed in Sweden, twenty female patients suffering from biomedically undefined 
musculoskeletal pain were selected.  The study found clear issues of loss of control 
for patients and their bodies, self-blame, self-perception, and legitimization of their 
illness.200  Another study by Miles et al. describes the experience of 29 patients with 
chronic pain interviewed at an outpatient clinic.  The researchers developed a model 
of basic social psychological process where patients attempted to maintain a normal 
life under the constraint of pain.  Three constraints were identified: bodily constraint, 
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activity constraint, and identity constraint.  Each perceived constraint yielded a new 
definition of normalcy for pain patients where patients assimilated, accommodated, 
confronted or subverted:  
In assimilation, the constraints were absorbed and normal life maintained.  In 
confrontation, the constraints were rejected and pre-pain identities and activities 
pursued despite leading to increased pain levels.  In subversion, attempts were 
made to retain pre-pain identities, and although pain levels were minimized, 
activities were altered to a significant degree.201
We can see that patients who must cope with pain manifest their new identities in 
many different ways; however pain absolutely brings about lifestyle changes. 
Feinmann stresses the similarities between different types of unexplained 
chronic pain.  Some specific illnesses under the umbrella of chronic pain are 
Repetitive Strain Injury (RSI), Chronic Fatigue Syndrome (CSF), fibromyalgia (FM), 
and CRPS.  Statistics show that one in seven people suffer from chronic pain.  Many 
of these diseases are intractable “so that doctors, even at specialist pain clinics, have 
little to offer.”202   
Professor David Blake, consultant rheumatologist at the Royal National 
Hospital for Rheumatic Diseases in Bath offers a new explanation of pain symptoms 
that has to do with an imbalance in our sense of proprioception, the sense of limb 
position or movement. Medically unexplained pain is sometimes the result of a 
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nonpainful stimulus which can lead to pain.  For example, a light touch or loud sound 
can cause excruciating pain for a CRPS patient.  Other non-painful stimuli include 
taste, touch, visual, and auditory mechanisms.  One study on mirror visual 
biofeedback showed that patients who mimic movements of a healthy hand in a 
mirror have an analgesic effect for CRPS patients.  Dr. Candy McCabe says that 
visual manipulation may be a way to deal with pain as “every mother knows that 
distracting a baby before an injection lessens the pain.”203   Another experiment at 
University College Hospital (UCH) “proved that ‘real’ pain can indeed originate in 
the brain.”204  The experiment stemmed from the belief that “medically unexplained 
pain and fatigue as ‘all in the mind’ might have a point”.  The study conducted at 
UCH hypnotized a group of healthy individuals to believe that they were 
experiencing pain.  The second group of volunteers was “subjected to the real 
thing.”205  Brain scans during the tests “showed that both groups experienced similar 
brain activity.”206  Researcher Dr. David Oakley, director of the hypnosis unit at 
UCH commented “the fact that hypnosis was able to induce a genuine painful 
experience suggests that some pain really can begin in our minds.”207   
    Zavestoski et al. examine Gulf War illness (GWI) in relation to other 
medically unexplained physical symptoms such as chronic fatigue syndrome and 
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fibromyalgia.  Issues of diagnostic legitimacy are relevant to these diseases where 
“GWIs represent a growing  phenomena in which sufferers of medically unexplained 
symptoms struggle to get their symptoms recognized in order to receive the care they 
believe they need.”208 The symptoms of diseases like GWI, FM, and CFS are all very 
similar and there are many blanket terms that cover this disease category such as 
medically unexplained physical symptoms (MUPS), functional somatic syndromes, 
and chronic multisymptom illness.  “The fact that there are both overlapping 
diagnosis, and a variety of umbrella terms for these diseases/conditions, demonstrates 
the confusion surrounding them.”209  As we saw in this section the experts struggling 
to assess the origin of ‘real’ pain in chronic pain patients does not have one, single 
explanation.  Discrepancies over diseases with similar characteristic prove 
problematic when physicians determine diagnosis, coupled with different disciplinary 
views about the mind/brain relationship and its effects on pain.  
An overview of how researchers study different types of medically 
unexplained pain suggests that the traditional biomedical model of pain coupled with 
psychological aspects of pain studies can give a richer, more productive interpretation 
of pain management. However, discrepancies between professionals over the 
definition, origin, and treatment of pain reaffirm the longstanding disciplinary divide 
between neurology and psychiatry.  In addition, chronic pain patients often blame 
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themselves for their condition and struggle to regain order in their lives.  Although a 
theoretical discussion of the condition of pain patients is important, the following 
section introduces the patient narrative as one of the most important aspects of 
contemporary pain literature.  
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CHAPTER 11: CONCLUSION: PAIN PERSONIFIED 
Three CRPS patients who underwent the deep ketamine coma procedure in 
Germany describe their experiences as CRPS sufferers in the following section.  In 
addition to patient narratives are personal accounts of family members who are often 
affected by the disease of a loved one.  Another important aspect is the point of view 
of the physician, in this case Dr. Schwartzman, who was the primary neurologist for 
the three patients.   
  For patients like Dan DeFilippo, Lindsay Wurtenberg, and Susan Herera, 
undergoing the radical coma treatment was worth the risk.  Before the coma 
procedure, both Dan and Lindsay described their pain as 24/7 torture.  Lindsay states 
“I became suicidal.  If I was able to walk, I probably would have tried killing 
myself.”210  Dan’s pain was so excruciating that he suffered from black outs.  
Stepping on any object, even as little as a poppy seed, was unbearable. He recalls that 
“the most painful part of my day is putting on a sock.”211  Dan had tried every 
treatment “under the sun,” including holistic and alternative healing.  The desperation 
for relief from pain for Dan and Lindsay may be likened to Hans Christian 
Andersen’s “The Princess and the Pea” where even the smallest discomfort to the 
patient or the princess seems overwhelming.   
Unfortunately, since the procedure in Germany is not FDA approved and 
insurance does not cover the cost “only those who have the money to go are able to 
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get the treatment.”212  Many patients have raised funds on their own to receive the 
coma treatment.  Dr. Schwartzman characterizes his patient’s pain as the worst pain 
in medicine and hopes that with time they will be able to uncover exactly where the 
root of debilitating pain lies.213  
Long- time CRPS sufferer Vance Hudson described his struggle: “I am no longer 
employed.  I spent a year without any income at all.  It impacts relationships.  I am 
just not the same person I was.”214  Hudson’s struggle with feelings of hopelessness 
brought on by insufferable pain is representative of the daily strife many CRPS 
patients experience.  One anonymous female described her experience with the 
disorder as “It hurts just as bad on the fifth year as the day you got it . . . I still go to 
bed every night thinking maybe tomorrow I won’t wake up in any pain.  I still do that 
after 13 years.”215   For some patients, their hopelessness is forgotten the moment 
they first come in contact with Schwartzman.  One patient described her first 
impression of him after receiving many misdiagnoses from other doctors, as an 
omnipotent being in a white coat, he instantly knew what had been plaguing her for 
years with just a simple look.   
 Schwartzman affirms “the patients that we put in comas are intractable.  They 
have failed everything.  They have failed all known treatments for pain.  They 
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absolutely have no quality of life.  I don’t think there’s a worse pain problem.”216  It 
is common in pain studies to lay the burden of success and failure at the feet of the 
patient.  In neurological studies, physicians use particular words/ language to assign 
blame to the patient for failing the treatment.  Such language, although accepted 
clinically, may send counterproductive messages to patients who are in pain, creating 
unnecessary tension between the patient and physician.  For example, a patient with 
RSD (1989) who was treated by cingulumotomy is described in the study: “the 
patient, after failing to improve with repeated cingulumotomies, eventually 
underwent thalamic stimulation at another institution one year later but achieved no 
pain relief.”217  Dr. Diane Stelzer Morrow, discussing her experiences treating 
chronic pain patients estimates that over half of her patients with chronic illnesses 
blame themselves for their illness.  This notion of self-blame is prevalent in CRPS 
and “in syndromes like fibromyalgia and chronic pain, which, perhaps because they 
depend for their diagnosis on a largely subjective component, are often considered 
more  nebulous than, say, diabetes or hypertension.”218  Schwartzman eases the minds 
of his patients at once when telling them “it (CRPS) is absolutely not 
psychological.”219  
  Lindsay, the young teenage girl who had lost all hope at ever living a normal 
life again, who was placed in a drug induced coma was the only hope of climbing out 
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of her suicidal mindset.  Lindsay’s mother felt the radical treatment was necessary.  
Lindsay’s mother explains “I felt I had no other option. What else am I going to do?  
She couldn’t take care of herself. She couldn’t walk.  She wasn’t going to school. She 
had no interest in anything. All she talked about was dying actually [sic].  She 
constantly said: I don’t even want to live. This is just too much.  I can’t bare it 
anymore.”220   
Although undergoing the risky coma treatment did not seem like a choice at all 
for the Wurtenberg family, Lindsay’s father tearfully recalls the day his daughter 
woke up: “The five days felt like five months.  It was the longest five days of my life. 
They told us about there would be side effects.  And she woke up and didn’t know us.  
It just wasn’t my daughter and I was very scared.  And then when she did come out 
two days after the coma she came back to herself when she mentioned our names, she 
knew who we were, and we knew we had our little girl back.”221  While many hope 
they will simply wake up from this coma and not feel any pain, it is not as simple as 
that.  While receiving booster injections of ketamine after her trip from Germany, 
Susan Herara, a patient of Dr. Schwartzman’s, explains: “The change is gradual.  It 
doesn’t happen over night. This is two years and it’s a huge commitment on my part 
as a patient.  But on their part, they’ve guided me through everything.  And they 
never gave up on me.”222  The commitment involved in undergoing the coma 
treatment, by patients, their family, and the physician is another important aspect of 
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this story.  Barbara, mentioned earlier, had the option to undergo the treatment but 
she declined due to the inherent risks.   
Dan, the young adult who was injured in the car accident reiterates how the 
treatment took him from a lifeless individual who had given up hope on ever leading 
a normal life again and gave him back his ability to function and hope that the future 
could again be positive.  “I was in such a state of agony.  My life, my quality of life 
was non-existent.  Now I have everything looking up for me.  I truly am a changed 
man. It changed my life.”223   
Pain management is conducted in a multifaceted, subjective arena where the 
history of medical disciplines, legal institutions, and nations control avenues of 
patient care.  The rich and tumultuous history of neurology informs us of the way in 
which neurologists study pain today.  This thesis has shown that not all diseases are 
created equal even in the 21st century where the breadths of understanding certain 
diseases are weighed on an uneven and sometimes unfair scale.   
For anyone who has tuned in to popular media in past year, 2007 and 2008 
have been bombarded by media outreach campaigns to raise awareness for cancer and 
fibromyalgia.  As I have previously shown, these diseases share very similar 
characteristics with CRPS yet CRPS advocates have yet to see their cause receive 
widespread, mainstream attention.  A quick Google search shows hundreds of 
scholarly publications on CRPS as well as message boards where many suffers 
communicate with one another about their experiences with pain, their hope and their 
anguish, and where to find help.  Hope is alive because of forward thinking 
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researchers like Schwartzman who has made it his medical mission to ease the pain of 
CRPS sufferers.      
The story of Schwartzman, his patients, and his treatment teaches us that 
while pain is indeed a universal experience, it is not dealt with unanimously.  
Schwartzman is an example of a pain specialist who exhibits an exceptional range of 
creativity, compassion, and boldness when it comes to patient care and treatment.  His 
methods, albeit wavering on the side notable risk based on conventional scientific 
findings or regulatory policies, give patients the opportunity to take control of their 
fate and decide what is best for their bodies and their peace of mind.  The willingness 
of both patient and researcher to unite and share ownership of pain should be the new 
standard in pain management, like we see with Schwartzman and his patients.  CRPS 
and its coma treatment challenge conventional ideas about pain management and 
risk/benefit analysis.  Schwartzman is an example of a doctor who is moving away 
from the constraints of the conventional medical establishment and reform definitions 
of acceptable risk.    
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